Gennex Laboratories Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Gennex Laboratories Ltd. on BSE

Load latest

Gennex Laboratories Ltd.

30 Sep 2023

12.80

6.84%

SAST

GENNEX LABORATORIES LTD. - 531739 - Closure of Trading Window

BSE India

Notice is hereby given that in pursuance of SEBI (PIT) Regulations, 2015 and Company''s Code of Conduct for regulating, monitoring and reporting of Trading by Insiders, the Trading window for dealing in the securities of the Company shall remained closed from October 01, 2023 till 48 hours after the public announcement through Board of Directors in their meeting held for announcing the Unaudited Financial Results for the quarter ended September 30, 2023 along with other matters for which Trading window is required to be closed. The Board Meeting date to approve the Unaudited Financial Results of the Company for the quarter ended September 30, 2023 will be informed in due course. All Promoters /designated/connected persons are advised not to trade in the securities of the Company during the aforesaid period of Closure of Trading Window.

pdf

Gennex Laboratories Ltd.

30 Sep 2023

12.80

6.84%

AGM

GENNEX LABORATORIES LTD. - 531739 - Shareholder Meeting / Postal Ballot-Outcome of AGM

BSE India

Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we are pleased to provide hereunder the proceedings of 38th Annual General Meeting (AGM) of the Company held on Saturday September 30, 2023 through video conferencing (''VC'') / other audio visual means (''OA VM''). The meeting was held in compliance with MCA Circulars no. #14/2020 dated 08/04/2020, #02/2021 dated 13/01/2021 and # 02/2022 dated 05/05/2022 and SEBI Circulars no. SEBI/HO/CFD/CMD1/CIR/P/2020/79 dated 12/05/2020, # SEBI/HO/CFD/CRM2/CIR/P/2021/11 dated 15/01/2021 and # SEBI/HO/DDHS/P/CIR/2022/0063 dated 13.05.2022 and other applicable provisions of the Companies Act, 2013 and rules made thereunder. The meeting commenced at 12.30.Hrs and concluded at 12.40 Hrs. All the requisite Statutory Registers and other requisite documents were available electronically during the AGM for inspection of the members. The intimation is also uploaded in the Company website: www.gennexlab.com

pdf

Gennex Laboratories Ltd.

27 Sep 2023

12.80

6.84%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Disclosure Under Regulation 29 Of The SEBI (SAST) Regulations, 2011 …

BSE India

Pursuant to Regulation 29 of SEBI (SAST) Regulations, 2011 and Form C under Regulation 7(2) of SEBI (PIT) Regulations, 2015, this is to inform you that the Company has received the disclosure in prescribed format as per Regulation 29(1) and 29(2) of SEBI (SAST) Regulations, 2011 and Form C under Regulation 7(2) of SEBI (PIT) Regulations, 2015 from M/s Premier Fiscal Services Private Limited, Promoter of the Company, regarding purchase of 9,000 Equity Shares of Face value of Rs.1/- each of the Company through market sale on 21.09.2023. Please find enclosed the disclosures made by M/s Premier Fiscal services Private Limited in the Prescribed Form as per Regulation 29(1) and 29(2) of SEBI (SAST) Regulations, 2011 and Form C under Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations, 2015. This is for your kind information and record.

pdf

Gennex Laboratories Ltd.

16 Sep 2023

12.80

6.84%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Disclosure Under Regulation 29 Of The SEBI (SAST) Regulations, 2011 …

BSE India

Pursuant to Regulation 29 of the SEBI (SAST) Regulations, 2011 and Form C under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015, this is to inform you that the Company has received the disclosure in prescribed format as per Regulations 29(1) and 29(2) of SEBI (SAST) Regulations, 2011 and Form C under Regulation 7(2) of SEBI (PIT) Regulations, 2015 from M/s Premier Fiscal Services Private Limited., Promoter of the Company, regarding purchase of 29,000 Equity Shares of Face value of Rs. 1/- each through market sale on 14.09.2023 and 15.09.2023. Please find enclosed the disclosure made by M/s Premier Fiscal Services Private Limited on the Prescribed Form as per Regulations 29(1) and 29(2) of SEBI (SAST) Regulations, 2011 and Form C under Regulation 7(2) read with Regulation 6(2) of SEBI (PIT) Regulations, 2015. This is for your kind information and records.

pdf

Gennex Laboratories Ltd.

09 Sep 2023

12.80

6.84%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Please find enclosed herewith Newspaper Publication of AGM notice and eVoting related instructions advertisement cutting published in both Business Standard and Saksham on September 09, 2023 for the 38th Annual General Meeting of the Company to be held at September 30, 2023 We request you to take the above information record and acknowledge the receipt of the same.

pdf

Gennex Laboratories Ltd.

09 Sep 2023

12.80

6.84%

Corp. Note

GENNEX LABORATORIES LTD. - 531739 - Reg. 34 (1) Annual Report.

BSE India

we hereby submits the 38th Annual Report of Gennex Laboratories Limited ('the Company') for the Financial Year ended March 31, 2023, along with the Notice of the 38th Annual General Meeting to be held on September 30, 2023, have been sent electronically to the members who have registered their email ID as per the SEBI guideline. The aforesaid documents are available on the Company website i.e., www.gennexlab.com, and are also available for inspection at the Registered Office of the Company during office hours Further, inform you that U/Sec. 108 of the Companies Act, 2013 and the Rules, 2014, as amended, and Reg.44 of SEBI (LODR) Regulations, 2015, the Company is pleased to provide its member''s facility to exercise their right to vote on resolutions proposed to be passed in the AGM, by electronic means. The details as per the provisions of the Companies Act, 2013 are given in the attached Notice. This intimation is also uploaded on the Company website: www.gennexlab.com

pdf

Gennex Laboratories Ltd.

06 Sep 2023

12.80

6.84%

Board Meeting

GENNEX LABORATORIES LTD. - 531739 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

In just concluded Meeting of Board of Directors, the Board Approved and considered the following items: 1. Draft Directors''/ Board Report for the Financial Year March 31, 2023; 2. The 38th Annual General Meeting of the Company to be held on Saturday, September 30, 2023 at 12:30 P.M.; 3. Secretarial Audit Report issued by Mr. Rakesh Kumar Gupta, Practicing Company Secretary, Kolkata; 4. Appointment of Ms. Ekta Goswami, Practicing Company Secretary, Kolkata as Scrutinizer for the AGM; 5. Book Closure Date in connection with 38th AGM between September 23, 2023 to September 30, 2023; 6. Appointment of Mr. Rakesh Kumar Gupta, Practicing Company Secretary, Kolkata as a Secretarial Auditor for the Financial Year 2023-24. We hereby submit that the Board Meeting had commenced at 04:30 PM and concluded at 05:00 PM. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

06 Sep 2023

12.80

6.84%

Corp. Action

GENNEX LABORATORIES LTD. - 531739 - Intimation Of Book Closure Of Gennex Laboratories Limited - BSE …

BSE India

Pursuant to Regulation 42 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) Regulations, 2015 the Register of Members and Share Transfer Books of the Company will remain closed from September 23, 2023 to September 30, 2023 (both days inclusive) for the purpose of the 38th Annual General Meeting (AGM) to be held on Saturday, September 30, 2023, for the Financial year 2022-23. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge the receipt.

pdf

Gennex Laboratories Ltd.

29 Aug 2023

12.80

6.84%

Board Meeting

GENNEX LABORATORIES LTD. - 531739 - Board Meeting Intimation for Intimation Of Board Meeting To Be …

BSE India

GENNEX LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/09/2023 ,inter alia, to consider and approve With reference to the above captioned subject matter, pursuant to the referred regulations of SEBI (LODR) Regulations, 2015 mentioned above, we hereby inform you that the Meeting of Board of Directors of the Company will be held on Wednesday, September 06, 2023 at 04.30 P.M. at its Corporate Office at Akash Ganga, Plot 144, Srinagar Colony, Hyderabad, Telangana, 500073, inter alia, to consider the following matters, among other items of agenda: 1. To decide regarding the conduct of 38th AGM for the year ended March 31, 2023; 2. To Consider and Appoint Scrutinizer of the 38th Annual General Meeting in case of Finalisation of the Date of AGM; 3. Any other business with permission of the Chairperson. This intimation is also being uploaded on the Company website: www.gennexlab.com. We request you to take the above information on record and acknowledge receipt of the same.

pdf

Gennex Laboratories Ltd.

17 Aug 2023

12.80

6.84%

Company Update

GENNEX LABORATORIES LTD. - 531739 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, please find enclosed herewith Newspaper Publication of Unaudited (Standalone and Consolidated) Financial results for the First Quarter ended June 30, 2023 announced by the Board of Directors in its meeting held on Monday. August 14, 2023. Financial Results had been published in both Business Standard (English) and Saksham (Telugu-Local) on Thursday August 17, 2023.

pdf

Is Gennex Laboratories Ltd. worth buying?

129 Votes:

Buy 83.72%

Sell 6.2%

Hold 10.08%